Apart from those described above, the following antigens have either been examined for AML or are being investigated: CD7, CD13, CD19, CD34, CD38, CD56, CD117, B7-H3, mesothelin, NKG2D ligands, IL-10 receptor, GM-CSF receptor, ILT3, TIM-3, MUC-1, Lewis Y, and folate receptor β [46,100,101,102,103,104,105,106,107,108,109] (Table 1). This evidence concerns the gene CD19 and acute myeloid leukemia.